Search

everythinglearnresearchcommunity

for

Search:↓

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

M-CSF-stimulated myeloid cells can turn into skin cells and help heal wounds and regrow hair.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Mouse and human keratin 16 can both form filaments, with differences likely due to the tail domain, not the helical domain.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Canine hair follicle cells show stem cell properties, aiding hair growth.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

ABCG2 protein marks stem-like skin cells in human epidermis.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.